Recent oncology breakthroughs showcase innovative treatments and approvals, enhancing patient outcomes in CLL, RCC, NSCLC, ...

GSK gets FDA breakthrough status for its B7-H3 directed ADC, licensed from Hansoh Pharma in a $1.7bn deal last year, for small cell lung cancer.

What Triggered the Stock Surge: The company expanded rapidly into weight loss programs, launching GLP-1 medication access and ...